Oku, Naoto
University of Shizuoka,
Japan
2025 Rank: 56160
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 470 out of 157499 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 56160 | 46231 |
| Total Cites | 10135 | 12660 |
| H-index | 50 | 59 |
| Hm-index | 24 | 27 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 125 | 154 |
| Number of Single+First Authored Papers | 48 | 48 |
| Total Cites to Single+First Authored Papers | 1205 | 1465 |
| Number of Single+First+Last Authored Papers | 261 | 261 |
| Total Cites to Single+First+Last Authored Papers | 6867 | 8692 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 8402 | 9179 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.38 |
| Self-Citation Percentage |
19.94%
|
|
Oku, Naoto
University of Shizuoka,
Japan
2024 Rank: 54753
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 459 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 54753 | 44802 |
| Total Cites | 9614 | 12107 |
| H-index | 48 | 57 |
| Hm-index | 23 | 27 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 118 | 147 |
| Number of Single+First Authored Papers | 48 | 48 |
| Total Cites to Single+First Authored Papers | 1162 | 1422 |
| Number of Single+First+Last Authored Papers | 261 | 261 |
| Total Cites to Single+First+Last Authored Papers | 6548 | 8359 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7956 | 8716 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.39 |
| Self-Citation Percentage |
20.59%
|
|
Oku, Naoto
Teikyo University,
Japan
2023 Rank: 53597
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 466 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 53597 | 44056 |
| Total Cites | 9051 | 11515 |
| H-index | 48 | 55 |
| Hm-index | 22 | 26 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 108 | 137 |
| Number of Single+First Authored Papers | 48 | 48 |
| Total Cites to Single+First Authored Papers | 1127 | 1387 |
| Number of Single+First+Last Authored Papers | 259 | 259 |
| Total Cites to Single+First+Last Authored Papers | 6195 | 7994 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7493 | 8241 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.40 |
| Self-Citation Percentage |
21.40%
|
|
Oku, Naoto
Teikyo University,
Japan
2022 Rank: 51717
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 455 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 51717 | 42697 |
| Total Cites | 8460 | 10872 |
| H-index | 46 | 53 |
| Hm-index | 22 | 25 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 104 | 132 |
| Number of Single+First Authored Papers | 48 | 48 |
| Total Cites to Single+First Authored Papers | 1090 | 1349 |
| Number of Single+First+Last Authored Papers | 259 | 259 |
| Total Cites to Single+First+Last Authored Papers | 5819 | 7591 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6994 | 7729 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.41 |
| Self-Citation Percentage |
22.19%
|
|
Oku, Naoto
Teikyo University,
Japan
2021 Rank: 51189
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 466 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 51189 | 40846 |
| Total Cites | 8162 | 10524 |
| H-index | 44 | 53 |
| Hm-index | 21 | 25 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 101 | 129 |
| Number of Single+First Authored Papers | 48 | 48 |
| Total Cites to Single+First Authored Papers | 1068 | 1327 |
| Number of Single+First+Last Authored Papers | 257 | 257 |
| Total Cites to Single+First+Last Authored Papers | 5629 | 7377 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6749 | 7467 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.41 |
| Self-Citation Percentage |
22.44%
|
|
Oku, Naoto
University of Shizuoka,
Japan
2020 Rank: 50734
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 439 out of 94611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 50734 | 39375 |
| Total Cites | 7610 | 9839 |
| H-index | 41 | 50 |
| Hm-index | 20 | 24 |
| Number of Single Authored Papers | 8 | 8 |
| Total Cites to Single Authored Papers | 93 | 120 |
| Number of Single+First Authored Papers | 48 | 48 |
| Total Cites to Single+First Authored Papers | 1022 | 1279 |
| Number of Single+First+Last Authored Papers | 257 | 257 |
| Total Cites to Single+First+Last Authored Papers | 5196 | 6870 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6302 | 6968 |
| Ratio of Total Citations to Distinct Citing Papers | 1.21 | 1.41 |
| Self-Citation Percentage |
22.65%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.